Exicure (XCUR) Cash from Investing Activities (2016 - 2025)
Exicure's (XCUR) quarterly Cash from Investing Activities came in at $455000.0 in Q4 2025, up 321.3% on a QoQ basis from $108000.0 in Q3 2025.
Exicure (XCUR) Cash from Investing Activities (2016 - 2025) Analysis & Trends
Exicure (XCUR) has 9 years of Cash from Investing Activities data on file, last reported at $455000.0 in Q4 2025.
- Quarterly Cash from Investing Activities changed N/A year-over-year to $455000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $283000.0 (up 113.54% YoY) and the FY2025 annual result came in at -$1.8 million, changed N/A from the prior year.
- Cash from Investing Activities grew to $455000.0 in Q4 2025, from $108000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $19.2 million in Q2 2021 to a low of -$2.1 million in Q1 2025.
- A 4-year average of $3.0 million and a median of $711000.0 in 2023 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2021 — Cash from Investing Activities jumped 443.7% — and 2023, when it slumped 226.67%.
- Tracing XCUR's Cash from Investing Activities over 4 years: stood at $4.1 million in 2021, then sank by 94.96% to $207000.0 in 2022, then jumped by 243.48% to $711000.0 in 2023, then sank by 36.01% to $455000.0 in 2025.
- The last three Cash from Investing Activities figures came in at $455000.0 (Q4 2025), $108000.0 (Q3 2025), and -$280000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 329.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -49.35 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -363.46 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3.17 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 24.51 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -229.72 Mn |
| 10 | Exicure | 7.27 Mn | 7.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 455,000.00 |
| Dec 31, 2025 | 455,000.00 |
| Sep 30, 2025 | 108,000.00 |
| Sep 30, 2025 | 108,000.00 |
| Jun 30, 2025 | -280,000.00 |
| Jun 30, 2025 | -280,000.00 |
| Mar 31, 2025 | -2.09 Mn |
| Mar 31, 2025 | -2.09 Mn |
| Dec 31, 2023 | 711,000.00 |
| Dec 31, 2023 | 711,000.00 |
| Jun 30, 2023 | -1.90 Mn |
| Jun 30, 2023 | -1.90 Mn |
| Mar 31, 2023 | 106,000.00 |
| Mar 31, 2023 | 106,000.00 |
| Dec 31, 2022 | 207,000.00 |
| Dec 31, 2022 | 207,000.00 |
| Sep 30, 2022 | 998,000.00 |
| Sep 30, 2022 | 998,000.00 |
| Jun 30, 2022 | 1.50 Mn |
| Jun 30, 2022 | 1.50 Mn |